READY-2-GO
NEURONAL MITOCHONDRIAL HEALTH
ASSAY SERVICE

 MITOCHONDRIAL DYSFUNCTION: A HALLMARK OF MANY NEURODEGENERATIVE DISEASES

Assessing mitochondrial health in early-stage drug development is proving crucial in understanding drug candidates' impact on the broader, cell-health continuum. As mitochondrial malfunction is increasingly implicated in the onset of neuronal dysfunction/death in diseases such as Alzheimer’s, Parkinson’s, and dementia, efforts in developing drugs that mitigate these effects are expanding. 

Our Ready-2-Go Assay Service provides multiplexed measurements of mitochondrial quantity, location, and functionality using human, iPSC-derived, glutamatergic neurons.